ABL is global CDMO and CRO specializing in development, manufacturing and immunological testing of virus for vaccine candidates, gene and cancer therapies.
Our mission is to provide cGMP viral vectors from development to market, contributing to the success of our clients' immuntherapy innovations.
CDMO services include process development and validation, bulk drug substance, aseptic fill/finish and bioanalytical testing.
CRO services include immune response characterization, phenotypic, functional, PCR & virological assays, multiplexed biomarker measurement.